Francesca Tentori
Overview
Explore the profile of Francesca Tentori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
3967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ratkalkar V, Marlowe G, Sibbel S, Tentori F, Brunelli S, Karpinski S
Hemodial Int
. 2025 Jan;
PMID: 39888257
Introduction: Chronic kidney disease-mineral and bone disorder (CKD-MBD), is a common syndrome in end stage kidney disease (ESKD) patients, is marked by dysregulation of electrolytes and hormones, including calcium, phosphorus...
2.
Naljayan M, Hunt A, McKeon K, Marlowe G, Schreiber M, Brunelli S, et al.
J Nephrol
. 2023 Aug;
36(7):1897-1905.
PMID: 37644364
Background: Incremental peritoneal dialysis (PD) can be defined as a PD prescription that is less than the standard, full dose prescription and is typically used for patients initiating PD with...
3.
Grandinetti A, Hilliard-Boone T, Wilund K, Logan D, St Peter W, Wingard R, et al.
Kidney360
. 2023 Apr;
4(6):e734-e743.
PMID: 37036682
No abstract available.
4.
Dalrymple L, Young E, Mk Farag Y, Fischer M, Hamilton E, Hussein W, et al.
Kidney Med
. 2022 Jul;
4(8):100495.
PMID: 35879977
The end-stage kidney disease (ESKD) Data Standards Project was launched by the Kidney Health Initiative (KHI) with the goal of standardizing dialysis-related measurements for research use. KHI is a public-private...
5.
McKeon K, Sibbel S, Brunelli S, Matheson E, Lefeber N, Epps M, et al.
Kidney Med
. 2022 Jul;
4(7):100490.
PMID: 35801188
Rationale & Objective: Treatment options for kidney failure are complex, and the majority of patients transitioning to dialysis lack important information about treatment options and are not prepared to make...
6.
Richardson M, Grandinetti A, Hilliard-Boone T, Wilund K, Wingard R, St Peter W, et al.
Clin J Am Soc Nephrol
. 2022 Mar;
17(10):1563-1574.
PMID: 35292531
Skeletal muscle cramping is a common and bothersome symptom for patients on maintenance dialysis therapy, regardless of modality, and it has not been prioritized for innovative assessments or treatments. Research...
7.
Karpinski S, Sibbel S, Cohen D, Colson C, Van Wyck D, Ghaffari A, et al.
Perit Dial Int
. 2022 Mar;
43(2):186-189.
PMID: 35272530
The majority of end-stage kidney disease (ESKD) patients start dialysis without adequate pre-dialysis planning. Of these patients, the vast majority initiate in-centre haemodialysis using a central venous catheter (ICHD-CVC). A...
8.
Brunelli S, Sibbel S, Karpinski S, Marlowe G, Walker A, Giullian J, et al.
J Am Soc Nephrol
. 2022 Feb;
33(4):688-697.
PMID: 35135894
Background: Studies have demonstrated that mRNA-based SARS-CoV-2 vaccines are highly effective among patients on dialysis. Because individual vaccines may be differentially available or acceptable to patients, it is important to...
9.
Sibbel S, McKeon K, Luo J, Wendt K, Walker A, Kelley T, et al.
J Am Soc Nephrol
. 2021 Nov;
33(1):49-57.
PMID: 34789546
Background: Patients on hemodialysis have an elevated risk for COVID-19 but were not included in efficacy trials of SARS-CoV-2 vaccines. Methods: We conducted a retrospective, observational study to estimate the...
10.
Parmeggiani F, Brenna E, Colombo D, Gatti F, Tentori F, Tessaro D
Chembiochem
. 2021 Sep;
23(1):e202100445.
PMID: 34586700
Ene-reductases from the Old Yellow Enzyme (OYE) superfamily are a well-known and efficient biocatalytic alternative for the asymmetric reduction of C=C bonds. Considering the broad variety of substituents that can...